Farmaka

Farmaka

Milan, Italy· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Farmaka is a long-established, private Italian company with over four decades of experience in the pharmaceutical and medical device industry. It has carved a niche in dermatology and wound care, developing and manufacturing its own portfolio of small molecule-based products. As a vertically integrated entity, it likely controls aspects from development to commercialization, targeting the European and potentially global markets for skin health and wound management. Its maturity suggests a stable, revenue-generating business model focused on specialized therapeutic areas.

DermatologyWound Care

Technology Platform

Formulation and delivery platform for topical small molecule pharmaceuticals and development of medical device matrices for wound management.

Opportunities

Growth in the aging population and rising prevalence of chronic wounds (e.g., diabetic ulcers) drives demand in wound care.
Expansion into adjacent aesthetic dermatology or OTC skincare represents a high-margin opportunity.
Geographic expansion beyond core European markets could provide new revenue streams.

Risk Factors

Intense competition from large multinationals and generic manufacturers pressures pricing and market share.
Evolving and stringent European regulations (MDR, EMA) increase compliance costs and complexity.
Reliance on a portfolio of mature products requires continuous innovation to avoid revenue decline from generication.

Competitive Landscape

Farmaka operates in competitive markets dominated by global leaders like Galderma in dermatology and Smith & Nephew/Mölnlycke in advanced wound care. It competes by focusing on niche formulations, cost-effectiveness, and deep regional expertise in Italy and Europe. Differentiating through specialized products and strong relationships with healthcare providers is key to maintaining its position.